Skip to Main Content

Paper Details

Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.
J Natl Cancer Inst
44
2020
AA, ATM, BRCA1, BRCA2, Breast Cancer, CHEK2, ER, ER-negative disease, ER-positive breast cancer, ER-positive cancer, ERCC3, FANCC, FANCC mutations, Germline, Germline DNA, Germline DNA samples, Germline Predisposition Gene, PALB2, QIAseq multiplex amplicon panel, RAD51D, RECQL, RECQL mutations, Women, breast cancer, breast cancer predisposition genes, cancer, cancer predisposition genes, estrogen, estrogen receptor, estrogen receptor (ER)-negative breast cancer, genes, hereditary cancer, multigene, panel, patients, women
Author NameAffiliation
Eric C PolleyMayo Clinic
Eric C PolleyMayo Clinic
Esther M JohnStanford University School of Medicine
Christopher A HaimanUniversity of Southern California
Christopher A HaimanUniversity of Southern California
Mia M Gaudet
Hoda Anton-Culver
Hoda Anton-Culver
Leslie Bernstein
Christine B AmbrosoneRoswell Park Comprehensive Cancer Center
Christine B AmbrosoneRoswell Park Comprehensive Cancer Center
Elisa V BanderaRutgers Cancer Institute of New
Loic Le MarchandUniversity of Hawaii Cancer Center Honolulu
Susan M DomchekAbramson Cancer Center and Basser Center for BRCA, University of Pennsylvania, Huntsman Cancer Institute, University of Utah
David E GoldgarBoston University School of Medicine
David E GoldgarVanderbilt University Medical Center
David E GoldgarBoston University School of Medicine
David E GoldgarVanderbilt University Medical Center
Katherine L NathansonAbramson Cancer Center and Basser Center for BRCA, University of Pennsylvania, Huntsman Cancer Institute, University of Utah
Peter KraftMayo Clinic
Peter KraftMayo Clinic
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
  • 1 - 23

Datasets

Release 1.2